186 related articles for article (PubMed ID: 2761375)
21. Complication probability as assessed from dose-volume histograms.
Lyman JT
Radiat Res Suppl; 1985; 8():S13-9. PubMed ID: 3867079
[TBL] [Abstract][Full Text] [Related]
22. [Optimum placement of radiation sources in the planning of interstitial radiotherapy].
Zamiatin OA; Sushchikhina MA; Klepper LA
Med Radiol (Mosk); 1986 Oct; 31(10):23-8. PubMed ID: 3773657
[TBL] [Abstract][Full Text] [Related]
23. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
24. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
25. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
26. [Dosimetric characteristics and radiobiological model of the irradiation of malignant tumors through a grid].
Lisin VA
Med Radiol (Mosk); 1984 Nov; 29(11):80-5. PubMed ID: 6503651
[TBL] [Abstract][Full Text] [Related]
27. [A method of the interactive visual optimization of the therapeutic dose field in contact radiation therapy of malignant tumors (theoretical aspects of the problem)].
Klepper LIa
Med Tekh; 2003; (5):27-32. PubMed ID: 14603847
[TBL] [Abstract][Full Text] [Related]
28. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
29. [The absorbed dosage and its fractionation in the radiation treatment of tumors in children].
Goldobenko GV; Ivanov VK; Durenov LA; Lobanov GV; Waĭnson AA
Med Radiol (Mosk); 1990 Jan; 35(1):14-7. PubMed ID: 2308494
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
[TBL] [Abstract][Full Text] [Related]
31. [Formation of optimum dose fields in contact radiation therapy of malignant tumors].
Klepper LIa
Med Tekh; 2003; (2):38-44. PubMed ID: 12924220
[TBL] [Abstract][Full Text] [Related]
32. [Mathematical modeling of optimal dose fields in radiotherapy of malignant tumors. Part 2 (Contact methods of radiotherapy)].
Klepper LIa
Med Tekh; 2004; (4):27-32. PubMed ID: 15455820
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of using internal radiation-generating devices in radiotherapy.
Bevelacqua JJ
Health Phys; 2010 Apr; 98(4):614-20. PubMed ID: 20220369
[TBL] [Abstract][Full Text] [Related]
34. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
35. [Possibilities and limitations of isoeffective models in the assessment of the equivalence of courses of fractionated irradiation].
Akimov AA; Kozlov AP
Med Radiol (Mosk); 1991; 36(9):14-9. PubMed ID: 1943578
[TBL] [Abstract][Full Text] [Related]
36. [A mathematical model for describing radiation complications].
Klepper LIa
Med Radiol (Mosk); 1988 Feb; 33(2):23-8. PubMed ID: 3343901
[TBL] [Abstract][Full Text] [Related]
37. [Determination of optimal irradiation conditions in relation to the frequency of radiation-induced complications in normal organs and tissues].
Klepper LIa
Med Radiol (Mosk); 1982 Jun; 27(6):18-22. PubMed ID: 7109860
[No Abstract] [Full Text] [Related]
38. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
[TBL] [Abstract][Full Text] [Related]
39. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
[TBL] [Abstract][Full Text] [Related]
40. [Nonuniform dose distributions in normal body organs and tissues in the radiotherapy of malignant tumors].
Klepper LIa
Med Tekh; 1999; (5):6-10. PubMed ID: 10560087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
